Clinical Research Directory
Browse clinical research sites, groups, and studies.
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
Sponsor: Stemline Therapeutics, Inc.
Summary
This is a first-in-human study of MEN2312, a lysine acetyltransferase 6 (KAT6) inhibitor, in adult participants with advanced breast cancer.
Official title: A Phase 1, First-in-Human Study of MEN2312, a KAT6 Inhibitor, as Monotherapy and in Combination in Participants With Advanced Breast Cancer
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
240
Start Date
2024-10-25
Completion Date
2026-10
Last Updated
2026-03-11
Healthy Volunteers
No
Conditions
Interventions
MEN2312
MEN2312 administered as oral tablets.
Elacestrant
Elacestrant administered as oral tablets.
Locations (30)
Highlands Oncology Group
Springdale, Arkansas, United States
UC San Diego Moores Cancer Center
La Jolla, California, United States
UCSF Helen Diller Family Comprehensive Cancer Center
San Francisco, California, United States
UCLA Hematology Oncology - Parkside
Santa Monica, California, United States
Yale Comprehensive Cancer Center
New Haven, Connecticut, United States
Advent Health Orlando
Altamonte Springs, Florida, United States
Sarah Cannon Research Institute at Florida Cancer Specialists
Orlando, Florida, United States
Florida Cancer Specialists & Research Institute (FCS) - Sarasota
Sarasota, Florida, United States
Moffitt Cancer Center
Tampa, Florida, United States
Winship Cancer Institute, Emory University
Atlanta, Georgia, United States
Sidney Kimmel Comprehensive Cancer Center
Baltimore, Maryland, United States
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, United States
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
START Midwest - Oncology
Grand Rapids, Michigan, United States
Mayo Clinic
Rochester, Minnesota, United States
Astera Cancer Care
East Brunswick, New Jersey, United States
Perlmutter Cancer Center - Sunset Park
Brooklyn, New York, United States
Perlmutter Cancer Center at NYU Langone Hospital - Long Island
Mineola, New York, United States
Laura & Isaac Perlmutter Cancer Center at NYU Langone Health
New York, New York, United States
Providence Cancer Institute Franz Clinic
Portland, Oregon, United States
SCRI Oncology Partners Group
Nashville, Tennessee, United States
The University of Texas M.D. Anderson Cancer Center
Houston, Texas, United States
START San Antonio, LLC
San Antonio, Texas, United States
University of Texas Health Science Center San Antonio
San Antonio, Texas, United States
START Mountain
West Valley City, Utah, United States
NEXT Virginia
Fairfax, Virginia, United States
University of Wisconsin Carbone Cancer Center
Madison, Wisconsin, United States
IOB - Madrid Fundacion Hermanas Hospitalarias (Hospital Beata Maria Ana)
Madrid, Spain
START Madrid - Hospital Universitario Fundacion Jimenez Diaz
Madrid, Spain
START Madrid - Centro Integral Oncologico Clara Campal (CIOCC), Hospital HM Sanchinarro
Madrid, Spain